# Do GLP-1 Drugs Weaken Your Bones? | Buy This GLP

Compare the evidence on GLP-1 drugs, bone density and fractures, including hip and pelvic fracture findings in the Wegovy label.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Safety

# Do GLP-1 Drugs Weaken Your Bones?

Fracture findings differ by population and fracture site. Here is what pooled studies, a bone density trial and the Wegovy label found.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20265 min readUpdated November 2026

Pooled fracture risk in type 2 diabetes · 1.0 · 0.80 · The result is compatible with lower or higher fracture risk. · 0.47 to 1.36 — wide enough to contain both directions.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   A pooled analysis of trials in type 2 diabetes did not establish whether GLP-1 drugs increase or decrease overall fracture risk.
-   In the Wegovy cardiovascular trial, the U.S. label reports more hip and pelvic fractures among women and adults aged 75 or older receiving Wegovy than in their placebo groups.
-   Bone density and fractures are separate outcomes. A small randomized semaglutide trial found lower spine and hip bone density after one year.

Findings on [femoral fractures in older adults with type 2 diabetes](https://buythisglp.com/research/half-the-fractures-two-in-a-thousand) concern a specific population and comparator. In those matched records, one-year rates were 0.3% for semaglutide versus 0.5% for a DPP-4 inhibitor, and 0.2% for tirzepatide versus 0.4% for a DPP-4 inhibitor in a separate cohort. The participants were at least 65 and had overweight or obesity. The study found an association and could not establish causation [\[1\]](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones#ref-1).

## What does the Wegovy label say?

In the cardiovascular outcomes trial, hip or pelvic fractures were reported in 1.0% of women receiving Wegovy versus 0.2% with placebo (24 of 2,448 versus 5 of 2,424). Among adults aged 75 and older, they were reported in 2.4% versus 0.6% (17 of 703 versus 4 of 663) [\[2\]](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones#ref-2). These groups can overlap. In a separate trial in adults with MASH, fractures were reported in 4.4% with Wegovy versus 3.3% with placebo [\[2\]](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones#ref-2). That figure covers fractures generally, while the cardiovascular trial figures above describe hip and pelvic fractures.

## What did the broader fracture evidence find?

A 2025 review of randomized trials in people with type 2 diabetes estimated a fracture risk ratio of 0.80 (95% CI 0.47 to 1.36). The interval leaves considerable uncertainty in both directions [\[3\]](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones#ref-3). A later review that also included observational studies found no clear difference in overall fractures, with substantial variation between studies [\[4\]](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones#ref-4).

## What happens to bone density?

A 52-week randomized study enrolled 64 adults at increased fracture risk. Once-weekly semaglutide showed no clear difference versus placebo on the primary bone formation marker. Bone density was lower at the lumbar spine and total hip, and a marker of bone breakdown was higher. The study was too small to determine whether fractures became more common[\[5\]](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones#ref-5).

If you have osteoporosis, a prior fracture or a high risk of falls, discuss your bone health with the clinician who manages your treatment.

## Frequently asked

Do GLP-1 drugs increase fracture risk?

The pooled evidence does not establish an overall effect. The Wegovy label does report more hip or pelvic fractures in women and people aged 75 and older receiving Wegovy than in their respective placebo groups in the cardiovascular outcomes trial.

Does semaglutide lower bone density?

A small 52-week randomized trial in adults at increased fracture risk found lower bone density at the lumbar spine and total hip with semaglutide versus placebo. The trial did not establish what happens to fracture risk.

## Sources

1.  \[1\] Chen HY, Wu JY, Chu YH, Chen TW, Huang CF (2026). Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes Osteoporosis International. [PMID 42435064](https://pubmed.ncbi.nlm.nih.gov/42435064/)
2.  \[2\] Novo Nordisk (2026). Wegovy U.S. prescribing information DailyMed. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3.  \[3\] Tan Y, et al. (2025). Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis Acta Diabetologica. [PMID 39985672](https://pubmed.ncbi.nlm.nih.gov/39985672/)
4.  \[4\] Beaudart C, et al. (2026). GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis Drugs. [PMID 42730869](https://link.springer.com/article/10.1007/s40265-026-02365-3)
5.  \[5\] Hansen MS, et al. (2024). Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial EClinicalMedicine. [PMID 38737002](https://pmc.ncbi.nlm.nih.gov/articles/PMC11087719/)

## More in Safety

-   [
    
    Follow the prescription · Storefront → pharmacy → label
    
    ### How to Verify an Online Pharmacy for GLP-1 Medication
    
    ](https://buythisglp.com/research/how-to-verify-online-pharmacy-for-glp1)
-   [
    
    Warm delivery? Pause first. · Save the evidence. Call the pharmacy.
    
    ### Semaglutide Arrived Warm? What to Do Before Using It
    
    ](https://buythisglp.com/research/semaglutide-arrived-warm)
-   [
    
    503A pharmacy · 503B facility · Prescription · per patient · or office stock · CGMP · exempt · required · Oversight · state license · FDA, risk-based · Adverse events · no FDA duty · must report · FDA approval · no · no
    
    ### 503A vs 503B Pharmacy Rules for Compounded GLP-1s
    
    ](https://buythisglp.com/research/503a-vs-503b-pharmacy-compounded-glp1)
